The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122615946 12261594 6 F 2013 20160916 20160413 20160920 EXP CA-ROCHE-1280556 ROCHE 69.22 YR F Y 75.00000 KG 20160920 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122615946 12261594 1 PS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) N B20162,B20262,B20172,B20383,B20233, 125276 280 MG SOLUTION FOR INFUSION
122615946 12261594 2 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) N B20162,B20262,B20172,B20383,B20233, 125276 544 MG SOLUTION FOR INFUSION
122615946 12261594 3 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) N B20162,B20262,B20172,B20383,B20233, 125276 SOLUTION FOR INFUSION
122615946 12261594 4 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) N B20162,B20262,B20172,B20383,B20233, 125276 560 MG SOLUTION FOR INFUSION
122615946 12261594 5 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) N B20162,B20262,B20172,B20383,B20233, 125276 560 MG SOLUTION FOR INFUSION
122615946 12261594 6 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) N B20162,B20262,B20172,B20383,B20233, 125276 SOLUTION FOR INFUSION
122615946 12261594 7 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) N B20162,B20262,B20172,B20383,B20233, 125276 520 MG SOLUTION FOR INFUSION
122615946 12261594 8 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) N B20162,B20262,B20172,B20383,B20233, 125276 600 MG SOLUTION FOR INFUSION
122615946 12261594 9 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) N B20162,B20262,B20172,B20383,B20233, 125276 SOLUTION FOR INFUSION
122615946 12261594 10 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) N B20162,B20262,B20172,B20383,B20233, 125276 300 MG SOLUTION FOR INFUSION
122615946 12261594 11 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) N B20162,B20262,B20172,B20383,B20233, 125276 280 MG SOLUTION FOR INFUSION
122615946 12261594 12 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) N B20162,B20262,B20172,B20383,B20233, 125276 308 MG SOLUTION FOR INFUSION
122615946 12261594 13 C M-ESLON MORPHINE SULFATE 1 0
122615946 12261594 14 C TYLENOL #4 2 0
122615946 12261594 15 C TRAZODONE TRAZODONE HYDROCHLORIDE 1 0
122615946 12261594 16 C ZOPICLONE ZOPICLONE 1 0
122615946 12261594 17 C VENLAFAXINE VENLAFAXINE HYDROCHLORIDE 1 0
122615946 12261594 18 C CODEINE CODEINE 1 0
122615946 12261594 19 C METHOTREXATE. METHOTREXATE 1 0
122615946 12261594 20 C GRAVOL DIMENHYDRINATE 1 0
122615946 12261594 21 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 0
122615946 12261594 22 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 0
122615946 12261594 23 C TYLENOL WITH CODEINE ACETAMINOPHENCODEINE PHOSPHATE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122615946 12261594 1 Rheumatoid arthritis
122615946 12261594 13 Pain
122615946 12261594 16 Insomnia
122615946 12261594 17 Depression

Outcome of event

Event ID CASEID OUTC COD
122615946 12261594 OT
122615946 12261594 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
122615946 12261594 Arthralgia
122615946 12261594 Blood pressure diastolic decreased
122615946 12261594 Drug effect decreased
122615946 12261594 Fall
122615946 12261594 Gastroenteritis
122615946 12261594 Haematoma
122615946 12261594 Heart rate increased
122615946 12261594 Hypotension
122615946 12261594 Influenza
122615946 12261594 Infusion related reaction
122615946 12261594 Injection site extravasation
122615946 12261594 Lung neoplasm malignant
122615946 12261594 Osteopenia
122615946 12261594 Oxygen saturation decreased
122615946 12261594 Pneumonia
122615946 12261594 Upper respiratory tract infection
122615946 12261594 Vascular fragility
122615946 12261594 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122615946 12261594 1 20111017 0
122615946 12261594 2 20120306 0
122615946 12261594 3 20130920 0
122615946 12261594 4 20140120 0
122615946 12261594 5 20131213 0
122615946 12261594 6 20140826 0
122615946 12261594 7 20150108 0
122615946 12261594 8 20150206 0
122615946 12261594 9 20150424 20150424 0
122615946 12261594 10 20151005 0
122615946 12261594 11 20160311 0
122615946 12261594 12 20160411 20160411 0